Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1993 1
1996 2
1997 4
1998 1
1999 3
2000 4
2001 3
2002 2
2003 1
2004 2
2005 2
2007 1
2010 1
2011 3
2012 2
2019 1
2020 1
2022 4
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
Elevated Adipocyte Membrane Phospholipid Saturation Does not Compromise Insulin Signaling.
Palmgren H, Petkevicius K, Bartesaghi S, Ahnmark A, Ruiz M, Nilsson R, Löfgren L, Glover MS, Andréasson AC, Andersson L, Becquart C, Kurczy M, Kull B, Wallin S, Karlsson D, Hess S, Maresca M, Bohlooly-Y M, Peng XR, Pilon M. Palmgren H, et al. Among authors: kull b. Diabetes. 2022 Dec 29:db220293. doi: 10.2337/db22-0293. Online ahead of print. Diabetes. 2022. PMID: 36580483
Dihydrexidine--the first full dopamine D1 receptor agonist.
Salmi P, Isacson R, Kull B. Salmi P, et al. Among authors: kull b. CNS Drug Rev. 2004 Fall;10(3):230-42. doi: 10.1111/j.1527-3458.2004.tb00024.x. CNS Drug Rev. 2004. PMID: 15492773 Free PMC article. Review.
Structure and function of adenosine receptors and their genes.
Fredholm BB, Arslan G, Halldner L, Kull B, Schulte G, Wasserman W. Fredholm BB, et al. Among authors: kull b. Naunyn Schmiedebergs Arch Pharmacol. 2000 Nov;362(4-5):364-74. doi: 10.1007/s002100000313. Naunyn Schmiedebergs Arch Pharmacol. 2000. PMID: 11111830 Review.
Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction.
Inghardt T, Antonsson T, Ericsson C, Hovdal D, Johannesson P, Johansson C, Jurva U, Kajanus J, Kull B, Michaëlsson E, Pettersen A, Sjögren T, Sörensen H, Westerlund K, Lindstedt EL. Inghardt T, et al. Among authors: kull b. J Med Chem. 2022 Sep 8;65(17):11485-11496. doi: 10.1021/acs.jmedchem.1c02141. Epub 2022 Aug 25. J Med Chem. 2022. PMID: 36005476 Free PMC article.
Correction to "Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction".
Inghardt T, Antonsson T, Ericsson C, Hovdal D, Johannesson P, Johansson C, Jurva U, Kajanus J, Kull B, Michaëlsson E, Pettersen A, Sjögren T, Sörensen H, Westerlund K, Lindstedt EL. Inghardt T, et al. Among authors: kull b. J Med Chem. 2022 Oct 13;65(19):13482. doi: 10.1021/acs.jmedchem.2c01533. Epub 2022 Oct 3. J Med Chem. 2022. PMID: 36190771 Free PMC article. No abstract available.
Family-wide chemical profiling and structural analysis of PARP and tankyrase inhibitors.
Wahlberg E, Karlberg T, Kouznetsova E, Markova N, Macchiarulo A, Thorsell AG, Pol E, Frostell Å, Ekblad T, Öncü D, Kull B, Robertson GM, Pellicciari R, Schüler H, Weigelt J. Wahlberg E, et al. Among authors: kull b. Nat Biotechnol. 2012 Feb 19;30(3):283-8. doi: 10.1038/nbt.2121. Nat Biotechnol. 2012. PMID: 22343925
38 results